PAUL L BERNS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL L BERNS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL L BERNS. PAUL L BERNS is a President/CEO in BONE CARE INTERNATIONAL INC ($BCII) and a Director in XENOPORT INC ($XNPT) and a Director in Jazz Pharmaceuticals plc ($JAZZ) and a Director in Cellectar Biosciences, Inc. ($CLRB) and a President and CEO in Anacor Pharmaceuticals, Inc. ($ANAC) and a Director in Unity Biotechnology, Inc. ($UBX) and a Director in Menlo Therapeutics Inc. ($MNLO).
Address: 1600 ASPEN COMMONS MIDDLETON 53562 WI
Companies in which PAUL L BERNS is an Insider
Anacor Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL L BERNS: President and CEO
Holdings: 0 shares
Latest Transaction: Jun 24 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BONE CARE INTERNATIONAL INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL L BERNS: President/CEO
Holdings: 0 shares
Latest Transaction: Jul 01 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cellectar Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL L BERNS: Director
Holdings: 117,371 shares
Current Value: $196,010
Latest Transaction: Apr 21 2016
$CLRB Market Capitalization: $9.82M
$CLRB Previous Close: $1.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Jazz Pharmaceuticals plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL L BERNS: Director
Holdings: 10,671 shares
Current Value: $1,334,409
Latest Transaction: Aug 10 2020
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Unity Biotechnology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL L BERNS: Director
Holdings: 3,261 shares
Latest Transaction: Jun 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VYNE Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL L BERNS: Director
Holdings: 0 shares
Latest Transaction: Jun 27 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
XENOPORT INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL L BERNS: Director
Holdings: 15,000 shares
Latest Transaction: May 19 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PAUL L BERNS
Sentiment: All, ANAC, BCII, CLRB, JAZZ, UBX, MNLO, XNPT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | UBX | Unity Biotechnolog ... | BERNS PAUL L | Director | Option Exercise | A | 4.18 | 25,000 | 104,500 | 25,000 | |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 125.87 | 931 | 117,185 | 9,740 | 10.7 K to 9.7 K (-8.72 %) |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 2,705 | 0 | 10,671 | 8 K to 10.7 K (+33.96 %) |
| Jun 22 2020 | UBX | Unity Biotechnolog ... | BERNS PAUL L | Director | Option Exercise | A | 9.14 | 25,000 | 228,500 | 25,000 | |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 135.65 | 726 | 98,481 | 7,966 | 8.7 K to 8 K (-8.35 %) |